SEC Comment Letter 0000000000-24-010838 to PRF Technologies Ltd. (PRFX)
PRF Technologies Ltd.
Date: Sept. 24, 2024 · CIK: 0001801834 · Accession: 0000000000-24-010838
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282264
Letter
September 24, 2024 Ehud Geller, Ph.D. Interim Chief Executive Officer PainReform Ltd. 65 Yigal Alon St. Tel Aviv, Israel 6744316 Re:PainReform Ltd. Registration Statement on Form F-3 Filed September 20, 2024 File No. 333-282264 Dear Ehud Geller, Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Mark Selinger, Esq.
Show Raw Text
September 24, 2024
Ehud Geller, Ph.D.
Interim Chief Executive Officer
PainReform Ltd.
65 Yigal Alon St.
Tel Aviv, Israel 6744316
Re:PainReform Ltd.
Registration Statement on Form F-3
Filed September 20, 2024
File No. 333-282264
Dear Ehud Geller, Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Mark Selinger, Esq.